Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Read
Synthetic Biologics & Proteon Therapeutics Stock Prices Soar 30% & 45%, Respectively, On News Of Designations From The FDA
Article By:
Lorimer Wilson
Thursday, May 11, 2017 10:17 AM EDT
The FDA handed out new breakthrough therapy designations for a whole slate of biotech drugs in the clinic and investors are still cheer each announcement with a big spike in stock prices: PRTO stock went up 46% on Wednesday; SYN's is up 30% today.
Forecasts And Recoupling
Article By:
Vivian Lewis
Wednesday, February 3, 2016 3:21 PM EDT
Yesterday's market closed barely dented by the renewed drop in the oil price, leading some experts to say this new linkage was now ended. The decoupling was ended in spades, with markets tumbling.
In this article: BP, TTM, FCAU, DGRLY, CZZ, SLB, CCJ, VE, TEVA, SYN, GSK, BSBR, BNS, LBTYA, VOD, PSHZF, NOK, VRX, PAH, EXG, ETW, PT, CVC, SAN
Synthetic Biologics Sinks 14% On Phase 2 Trial Failure For Relapsing-Remitting Multiple Sclerosis
Article By:
Terry Chrisomalis
Wednesday, February 3, 2016 2:39 AM EDT
With these clinical findings, the company has chosen to abandon the Trimesta program and focus clinical resources on two gut microbiome programs.
In this article: SYN
Synthetic Biologics Announces Positive Phase 2 Results For Prevention Of Bacterial Infection
Article By:
Terry Chrisomalis
Tuesday, December 1, 2015 8:30 PM EDT
Synthetic Biologics announces positive phase 2 results for prevention of bacterial infection
In this article: SYN